Immuno-oncology Clinical Trials Market Size, Share & Trends Analysis Report By Phase, By Design (Interventional Trials, Observational Trials, Expanded Access Trials), By Indication, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Immuno-oncology Clinical Trials Market Growth & Trends
The global immuno-oncology clinical trials market size is expected t%li%reach USD 18.7 billion by 2030, according t%li%a new report by Grand View Research, Inc. The market is expected t%li%expand at a CAGR of 12.1% from 2024 t%li%2030. The rapidly growing field of Immuno-oncology has emerged as a novel therapeutic area within the oncology ecosystem, transforming the treatment of cancer.
From 2014 t%li%2017, the number of new immuno-oncology studies increased from 250 t%li%almost 600, with double-digit growth rates each year as drug classes diversified. Biomarker and checkpoint inhibitor studies were primarily responsible for this rapid growth. While the immuno-oncology market is maturing in some pharmacological classes, cell therapies are exceeding all other immunotherapeutics in terms of growth. In March 2020, there were 1,483 active compounds in the pipeline for cancer cell therapy globally, indicating an increase of 472 from March 2019. The fastest-growing category was chimeric antigen receptor T (CAR-T) cell products (up 77% from 2019 t%li%2020).
Besides, during the Covid-19 pandemic, the number of IO drugs in development increased from 3,876 in 2019 t%li%4,720 in 2020, representing a 22% & 233% increase as compared t%li%2019 & 2017 respectively. After a moderate increase of 15% in 2019 compared t%li%68% between 2018 and 2017, this 22% increase indicates a return of interest in IO, despite the impact of the COVID-19 pandemic.
Immuno-oncology Clinical Trials Market Report Highlights
Immuno-oncology Clinical Trials Market Growth & Trends
The global immuno-oncology clinical trials market size is expected t%li%reach USD 18.7 billion by 2030, according t%li%a new report by Grand View Research, Inc. The market is expected t%li%expand at a CAGR of 12.1% from 2024 t%li%2030. The rapidly growing field of Immuno-oncology has emerged as a novel therapeutic area within the oncology ecosystem, transforming the treatment of cancer.
From 2014 t%li%2017, the number of new immuno-oncology studies increased from 250 t%li%almost 600, with double-digit growth rates each year as drug classes diversified. Biomarker and checkpoint inhibitor studies were primarily responsible for this rapid growth. While the immuno-oncology market is maturing in some pharmacological classes, cell therapies are exceeding all other immunotherapeutics in terms of growth. In March 2020, there were 1,483 active compounds in the pipeline for cancer cell therapy globally, indicating an increase of 472 from March 2019. The fastest-growing category was chimeric antigen receptor T (CAR-T) cell products (up 77% from 2019 t%li%2020).
Besides, during the Covid-19 pandemic, the number of IO drugs in development increased from 3,876 in 2019 t%li%4,720 in 2020, representing a 22% & 233% increase as compared t%li%2019 & 2017 respectively. After a moderate increase of 15% in 2019 compared t%li%68% between 2018 and 2017, this 22% increase indicates a return of interest in IO, despite the impact of the COVID-19 pandemic.
Immuno-oncology Clinical Trials Market Report Highlights
- Phase III dominated the market with the largest share of 53.2% in 2023. Oncology trials typically have fewer participants, are the most expensive, and involve larger sample sizes, resulting in a higher cost per participant.
- The interventional experiments accounted for more than 78.5% of the market share in 2023
- The segment of solid tumors held 55.9% of the revenue share in 2023. This is largely attributed t%li%the rise in the prevalence of solid tumors
- North America dominated the market and accounted for the largest revenue share of 50.3% in 2020. This is due t%li%the rising adoption of personalized medicine-focused novel treatment methods, as well as the government funding and investments
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. IMMUNO-ONCOLOGY CLINICAL TRIALS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Immuno-oncology Clinical Trials Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. IMMUNO-ONCOLOGY CLINICAL TRIALS MARKET: PHASE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Immuno-oncology Clinical Trials Market: Phase Movement Analysis, USD Billion, 2023 & 2030
4.2.1. Phase I
4.2.1.1. Phase I Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.2.2. Phase II
4.2.2.1. Phase II Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.2.3. Phase III
4.2.3.1. Phase III Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.2.4. Phase IV
4.2.4.1. Phase IV Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 5. IMMUNO-ONCOLOGY CLINICAL TRIALS MARKET: DESIGN ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Immuno-oncology Clinical Trials Market: Design Movement Analysis, USD Billion, 2023 & 2030
5.2.1. Interventional Trials
5.2.1.1. Interventional Trials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.2.2. Observational Trials
5.2.2.1. Observational Trials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.2.3. Expanded Access Trials
5.2.3.1. Expanded Access Trials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 6. IMMUNO-ONCOLOGY CLINICAL TRIALS MARKET: INDICATION ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Immuno-oncology Clinical Trials Market: Indication Movement Analysis, USD Billion, 2023 & 2030
6.2.1. Solid Tumors
6.2.1.1. Solid Tumors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.2.2. Hematological Cancer Healthcare
6.2.2.1. Hematological Cancer Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 7. IMMUNO-ONCOLOGY CLINICAL TRIALS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Immuno-oncology Clinical Trials Market Share, By Region, 2023 & 2030, USD Billion
7.2. North America
7.2.1. North America Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.2.2. U.S.
7.2.2.1. U.S. Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.2.3. Canada
7.2.3.1. Canada Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.2.4. Mexico
7.2.4.1. Mexico Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3. Europe
7.3.1. Europe Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.2. UK
7.3.2.1. U.K. Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.3. Germany
7.3.3.1. Germany Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.4. France
7.3.4.1. France Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.5. Italy
7.3.5.1. Italy Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.6. Spain
7.3.6.1. Spain Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.7. Denmark
7.3.7.1. Denmark Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.8. Sweden
7.3.8.1. Sweden Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.9. Norway
7.3.9.1. Norway Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4. Asia Pacific
7.4.1. Asia Pacific Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.2. Japan
7.4.2.1. Japan Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.3. China
7.4.3.1. China Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.4. India
7.4.4.1. India Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.5. Australia
7.4.5.1. Australia Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.6. South Korea
7.4.6.1. South Korea Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.7. Thailand
7.4.7.1. Thailand Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.5. Latin America
7.5.1. Latin America Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.5.2. Brazil
7.5.2.1. Brazil Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.5.3. Argentina
7.5.3.1. Argentina Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6.2. South Africa
7.6.2.1. South Africa Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6.4. UAE
7.6.4.1. UAE Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6.5. Kuwait
7.6.5.1. Kuwait Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. MEDPACE
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/Strategic Initiatives
8.4.2. Novartis
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/Strategic Initiatives
8.4.3. Exscientia
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/Strategic Initiatives
8.4.4. Syneous Health
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/Strategic Initiatives
8.4.5. AstraZeneca
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/Strategic Initiatives
8.4.6. IQ BIOTECH
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/Strategic Initiatives
8.4.7. BioNtech
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/Strategic Initiatives
8.4.8. IQVIA Holdings
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/Strategic Initiatives
8.4.9. ICON, Plc
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/Strategic Initiatives
8.4.10. Laboratory Corporation of America Holdings
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/Strategic Initiatives%%
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. IMMUNO-ONCOLOGY CLINICAL TRIALS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Immuno-oncology Clinical Trials Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. IMMUNO-ONCOLOGY CLINICAL TRIALS MARKET: PHASE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Immuno-oncology Clinical Trials Market: Phase Movement Analysis, USD Billion, 2023 & 2030
4.2.1. Phase I
4.2.1.1. Phase I Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.2.2. Phase II
4.2.2.1. Phase II Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.2.3. Phase III
4.2.3.1. Phase III Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.2.4. Phase IV
4.2.4.1. Phase IV Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 5. IMMUNO-ONCOLOGY CLINICAL TRIALS MARKET: DESIGN ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Immuno-oncology Clinical Trials Market: Design Movement Analysis, USD Billion, 2023 & 2030
5.2.1. Interventional Trials
5.2.1.1. Interventional Trials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.2.2. Observational Trials
5.2.2.1. Observational Trials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.2.3. Expanded Access Trials
5.2.3.1. Expanded Access Trials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 6. IMMUNO-ONCOLOGY CLINICAL TRIALS MARKET: INDICATION ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Immuno-oncology Clinical Trials Market: Indication Movement Analysis, USD Billion, 2023 & 2030
6.2.1. Solid Tumors
6.2.1.1. Solid Tumors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.2.2. Hematological Cancer Healthcare
6.2.2.1. Hematological Cancer Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 7. IMMUNO-ONCOLOGY CLINICAL TRIALS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Immuno-oncology Clinical Trials Market Share, By Region, 2023 & 2030, USD Billion
7.2. North America
7.2.1. North America Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.2.2. U.S.
7.2.2.1. U.S. Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.2.3. Canada
7.2.3.1. Canada Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.2.4. Mexico
7.2.4.1. Mexico Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3. Europe
7.3.1. Europe Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.2. UK
7.3.2.1. U.K. Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.3. Germany
7.3.3.1. Germany Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.4. France
7.3.4.1. France Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.5. Italy
7.3.5.1. Italy Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.6. Spain
7.3.6.1. Spain Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.7. Denmark
7.3.7.1. Denmark Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.8. Sweden
7.3.8.1. Sweden Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.9. Norway
7.3.9.1. Norway Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4. Asia Pacific
7.4.1. Asia Pacific Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.2. Japan
7.4.2.1. Japan Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.3. China
7.4.3.1. China Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.4. India
7.4.4.1. India Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.5. Australia
7.4.5.1. Australia Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.6. South Korea
7.4.6.1. South Korea Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.7. Thailand
7.4.7.1. Thailand Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.5. Latin America
7.5.1. Latin America Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.5.2. Brazil
7.5.2.1. Brazil Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.5.3. Argentina
7.5.3.1. Argentina Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6.2. South Africa
7.6.2.1. South Africa Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6.4. UAE
7.6.4.1. UAE Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6.5. Kuwait
7.6.5.1. Kuwait Immuno-oncology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. MEDPACE
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/Strategic Initiatives
8.4.2. Novartis
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/Strategic Initiatives
8.4.3. Exscientia
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/Strategic Initiatives
8.4.4. Syneous Health
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/Strategic Initiatives
8.4.5. AstraZeneca
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/Strategic Initiatives
8.4.6. IQ BIOTECH
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/Strategic Initiatives
8.4.7. BioNtech
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/Strategic Initiatives
8.4.8. IQVIA Holdings
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/Strategic Initiatives
8.4.9. ICON, Plc
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/Strategic Initiatives
8.4.10. Laboratory Corporation of America Holdings
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/Strategic Initiatives%%
LIST OF FIGURES
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, Market Segmentation
Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 Regional Marketplace: Key Takeaways
Fig. 12 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for API, 2018 - 2030 (USD Million)
Fig. 13 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Small Molecule, 2018 - 2030 (USD Million)
Fig. 14 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Large Molecule, 2018 - 2030 (USD Million)
Fig. 15 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Finished Drug Formulation, 2018 - 2030 (USD Million)
Fig. 16 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Solid Dosage Forms, 2018 - 2030 (USD Million)
Fig. 17 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Liquid Dosage Forms, 2018 - 2030 (USD Million)
Fig. 18 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Semi-solid Dosage Forms, 2018 - 2030 (USD Million)
Fig. 19 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Others, 2018 - 2030 (USD Million)
Fig. 20 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Medical Devices, 2018 - 2030 (USD Million)
Fig. 21 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Manufacturing Services, 2018 - 2030 (USD Million)
Fig. 22 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Clinical Manufacturing, 2018 - 2030 (USD Million)
Fig. 23 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Drug Product Development and Manufacturing, 2018 - 2030 (USD Million)
Fig. 24 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Fill Finish Manufacturing, 2018 - 2030 (USD Million)
Fig. 25 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Others, 2018 - 2030 (USD Million)
Fig. 26 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Regulatory Services, 2018 - 2030 (USD Million)
Fig. 27 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Regulatory Consulting, 2018 - 2030 (USD Million)
Fig. 28 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Regulatory Submissions, 2018 - 2030 (USD Million)
Fig. 29 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Compliance Audits, 2018 - 2030 (USD Million)
Fig. 30 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Others , 2018 - 2030 (USD Million)
Fig. 31 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Analytical Testing, 2018 - 2030 (USD Million)
Fig. 32 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Stability Testing, 2018 - 2030 (USD Million)
Fig. 33 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Method Development and Validation, 2018 - 2030 (USD Million)
Fig. 34 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Quality Control (QC) Testing, 2018 - 2030 (USD Million)
Fig. 35 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Bioanalytical Testing, 2018 - 2030 (USD Million)
Fig. 36 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Others, 2018 - 2030 (USD Million)
Fig. 37 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Others, 2018 - 2030 (USD Million)
Fig. 38 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Pharmaceutical Companies, 2018 - 2030 (USD Million)
Fig. 39 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Biotechnological Companies, 2018 - 2030 (USD Million)
Fig. 40 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Medical Device Companies, 2018 - 2030 (USD Million)
Fig. 41 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Others, 2018 - 2030 (USD Million)
Fig. 42 Regional Outlook, 2023 & 2030
Fig. 43 North America Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 44 U.S. Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 45 Canada Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 46 Mexico Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 47 Europe Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 48 Germany Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 49 UK Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 50 France Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 51 Italy Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 52 Spain Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 53 Denmark Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 54 Sweden Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 55 Norway Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 56 Asia Pacific Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 57 Japan Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 58 China Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 59 India Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 60 Australia Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 61 South Korea Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 62 Thailand Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 63 Latin America Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 64 Brazil Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 65 Argentina Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 66 Middle East and Africa Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 67 South Africa Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 68 Saudi Arabia Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 69 UAE Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 70 Kuwait Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, Market Segmentation
Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 Regional Marketplace: Key Takeaways
Fig. 12 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for API, 2018 - 2030 (USD Million)
Fig. 13 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Small Molecule, 2018 - 2030 (USD Million)
Fig. 14 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Large Molecule, 2018 - 2030 (USD Million)
Fig. 15 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Finished Drug Formulation, 2018 - 2030 (USD Million)
Fig. 16 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Solid Dosage Forms, 2018 - 2030 (USD Million)
Fig. 17 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Liquid Dosage Forms, 2018 - 2030 (USD Million)
Fig. 18 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Semi-solid Dosage Forms, 2018 - 2030 (USD Million)
Fig. 19 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Others, 2018 - 2030 (USD Million)
Fig. 20 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Medical Devices, 2018 - 2030 (USD Million)
Fig. 21 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Manufacturing Services, 2018 - 2030 (USD Million)
Fig. 22 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Clinical Manufacturing, 2018 - 2030 (USD Million)
Fig. 23 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Drug Product Development and Manufacturing, 2018 - 2030 (USD Million)
Fig. 24 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Fill Finish Manufacturing, 2018 - 2030 (USD Million)
Fig. 25 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Others, 2018 - 2030 (USD Million)
Fig. 26 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Regulatory Services, 2018 - 2030 (USD Million)
Fig. 27 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Regulatory Consulting, 2018 - 2030 (USD Million)
Fig. 28 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Regulatory Submissions, 2018 - 2030 (USD Million)
Fig. 29 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Compliance Audits, 2018 - 2030 (USD Million)
Fig. 30 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Others , 2018 - 2030 (USD Million)
Fig. 31 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Analytical Testing, 2018 - 2030 (USD Million)
Fig. 32 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Stability Testing, 2018 - 2030 (USD Million)
Fig. 33 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Method Development and Validation, 2018 - 2030 (USD Million)
Fig. 34 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Quality Control (QC) Testing, 2018 - 2030 (USD Million)
Fig. 35 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Bioanalytical Testing, 2018 - 2030 (USD Million)
Fig. 36 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Others, 2018 - 2030 (USD Million)
Fig. 37 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Others, 2018 - 2030 (USD Million)
Fig. 38 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Pharmaceutical Companies, 2018 - 2030 (USD Million)
Fig. 39 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Biotechnological Companies, 2018 - 2030 (USD Million)
Fig. 40 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Medical Device Companies, 2018 - 2030 (USD Million)
Fig. 41 Global Chemistry, Manufacturing, and Control (CMC) Services Outsourcing, for Others, 2018 - 2030 (USD Million)
Fig. 42 Regional Outlook, 2023 & 2030
Fig. 43 North America Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 44 U.S. Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 45 Canada Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 46 Mexico Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 47 Europe Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 48 Germany Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 49 UK Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 50 France Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 51 Italy Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 52 Spain Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 53 Denmark Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 54 Sweden Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 55 Norway Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 56 Asia Pacific Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 57 Japan Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 58 China Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 59 India Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 60 Australia Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 61 South Korea Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 62 Thailand Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 63 Latin America Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 64 Brazil Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 65 Argentina Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 66 Middle East and Africa Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 67 South Africa Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 68 Saudi Arabia Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 69 UAE Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 70 Kuwait Chemistry, Manufacturing, and Control (CMC) Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
